We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 523 results
  1. Anticipated reactions to learning Alzheimer’s disease biomarker results

    Introduction

    We developed the Alzheimer’s Biomarker Survey to assess willingness to enroll in biomarker studies that disclose results and anticipated...

    Lindsay R. Clark, Claire M. Erickson, ... Carey E. Gleason in Alzheimer's Research & Therapy
    Article Open access 22 June 2022
  2. Applications of Nanotechnology in Converging the Biomarker Science for Advancement in Cancer Detection and Treatment

    Cancer biomarkers with high selectivity, specificity, and reproducibility assume fundamental task in diagnosis, prognosis, and prediction of therapy...
    Akhil Khajuria, HemaKumari Alajangi, ... Indu Pal Kaur in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  3. Applications of Nanotechnology in Converging the Biomarker Science for Advancement in Cancer Detection and Treatment

    Cancer biomarkers with high selectivity, specificity, and reproducibility assume fundamental task in diagnosis, prognosis, and prediction of therapy...
    Akhil Khajuria, HemaKumari Alajangi, ... Indu Pal Kaur in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
  4. Quantitative Evaluation of Stance as a Sensitive Biomarker of Postural Ataxia Development in Preclinical SCA1 Mutation Carriers

    The aim of this study was to determine the time between the first detection of postural control impairments and the evident manifestation of ataxia...

    Anna Sobanska, Leszek Czerwosz, ... Maria Rakowicz in The Cerebellum
    Article 16 March 2024
  5. Ethical Considerations in Communicating Alzheimer’s Disease Neuroimaging Biomarker Test Results to Symptomatic Individuals

    This article examines ethical issues associated with the return of AD neuroimaging results to cognitively symptomatic individuals. Following a review...

    Daniel A. Wilkenfeld, Staci L. Orbell, Jennifer H. Lingler in Neurotherapeutics
    Article 15 April 2021
  6. Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review

    Background

    The NIA-AA research framework proposes a purely biological definition of Alzheimer’s disease (AD). This implies that AD can be diagnosed...

    Jetske van der Schaar, Leonie N. C. Visser, ... Wiesje M. van der Flier in Alzheimer's Research & Therapy
    Article Open access 10 February 2022
  7. Practices and opinions about disclosure of the diagnosis of Alzheimer’s disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia

    Previous surveys revealed that only a minority of clinicians routinely disclosed the diagnosis of Alzheimer’s disease (AD) to their patients. Many...

    Eric Mormont, Jean-Christophe Bier, ... Bernard Hanseeuw in Acta Neurologica Belgica
    Article 26 July 2020
  8. PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma

    Background

    Osteosarcoma was the most common primary bone malignancy in children and adolescents. It was imperative to identify effective prognostic...

    Feng Yao, Zhao Feng Zhu, ... **ao Dong Wang in Cancer Cell International
    Article Open access 17 July 2021
  9. Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer

    Background

    PDE9A (Phosphodiesterase 9A) plays an important role in proliferation of cells, their differentiation and apoptosis via intracellular cGMP...

    Tasmina Ferdous Susmi, Atikur Rahman, ... Mohammad Uzzal Hossain in BMC Cancer
    Article Open access 20 May 2021
  10. Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting

    Alzheimer’s disease (AD), the most common form of dementia, remains challenging to understand and treat despite decades of research and clinical...

    Xuemei Zeng, Yijun Chen, ... Thomas K. Karikari in Molecular Neurodegeneration
    Article Open access 15 May 2024
  11. The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection

    Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), has been the world’s driving fatal bacterial contagious disease globally. It continues...

    Rasoul Mirzaei, Sajad Babakhani, ... Rasoul Yousefimashouf in Molecular Medicine
    Article Open access 01 April 2021
  12. Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway

    Alzheimer’s disease (AD) is a complex, progressive primary neurodegenerative disease. Since pivotal genetic studies in 1993, the ε4 allele of the...

    Sneha Narasimhan, David M. Holtzman, ... Harald Hampel in Nature Neuroscience
    Article 19 June 2024
  13. Biomarkers for Cancer Drug Development

    Cancer biomarkers, which are indicators of cancer cells in the body, can help with diagnosis, prognosis, and treatment effectiveness as well as...
    Chapter 2022
  14. IL-8 as a potential biomarker in Guillain-Barre Syndrome

    This pilot study was designed to compare the levels of interleukin-8 (IL-8), a pro-inflammatory chemokine, in the cerebrospinal fluid (CSF) of...

    Gautier Breville, Agustina M. Lascano, ... Patrice H. Lalive in European Cytokine Network
    Article 01 December 2019
  15. Research Data Resources for Epidemiology

    This chapter introduces the data landscape that enables access to data resources for researching in the field of epidemiology. The chapter covers a...
    Louise Corti, Deborah Wiltshire in Integrative Bioinformatics
    Chapter 2022
  16. Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study

    Background

    Multiple clinical trials demonstrate consistent but modest benefit of adjuvant extended endocrine therapy (EET) in HR + breast cancer...

    Dennis C. Sgroi, Kai Treuner, ... John M. S. Bartlett in Breast Cancer Research
    Article Open access 16 December 2022
  17. Application of Metabolomics for the Discovery of Potent Antimicrobials from Plants

    One of the major goals of studying metabolome and metabolism has long been to find biomarkers for disease diagnosis and prognosis. The significance...
    Pramod Barathe, Sagar Reddy, ... Vinay Kumar in Medicinal Plants and Antimicrobial Therapies
    Chapter 2024
  18. Association of mTOR Pathway and Conformational Alterations in C-Reactive Protein in Neurodegenerative Diseases and Infections

    Inflammatory biomarkers have been very useful in detecting and monitoring inflammatory processes along with providing helpful information to select...

    Nitesh Kumar Poddar, Arshma Khan, ... Shahanavaj Khan in Cellular and Molecular Neurobiology
    Article 04 September 2023
  19. Dementia risk communication. A user manual for Brain Health Services—part 3 of 6

    Growing evidence suggests dementia incidence can be reduced through prevention programs targeting risk factors. To accelerate the implementation of...

    Leonie N. C. Visser, Carolina Minguillon, ... José Luis Molinuevo in Alzheimer's Research & Therapy
    Article Open access 11 October 2021
  20. Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer

    Background

    The diagnosis and surveillance of urothelial bladder cancer (UBC) require cystoscopy. There is a need for biomarkers to reduce the...

    Lauren Lett, Michael George, ... Chris Probert in British Journal of Cancer
    Article Open access 29 March 2022
Did you find what you were looking for? Share feedback.